CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY

被引：0
|
作者：
Laharie, D. [1 ]
Siegel, C. A. [2 ]
Samaan, K. [3 ]
Fisher, D. A. [3 ]
Morris, N. [3 ]
Redondo, I. [5 ]
Dulai, P. S. [4 ]
Jairath, V. [6 ]
Gisbert, J. P. [7 ]
Matsuoka, K. [8 ]
Orlando, A. [9 ]
机构：
[1] Ctr Hosp Univ Bordeaux, Bordeaux, France
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH USA
[3] Eli Lilly & Co, Indianapolis, IN USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[5] Eli Lilly Portugal, Prod Farmaceut, Lisbon, Portugal
[6] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[7] Univ Autonoma Madrid UAM, Inst Invest Sanitaria Princesa IIS Princesa, Hosp Univ Princesa, Gastroenterol Unit,Ctro Invest Biomed Red Enferme, Madrid, Spain
[8] Toho Univ, Div Gastroenterol & Hepatol, Sakura Med Ctr, Sakura, Chiba, Japan
[9] AO Villa Sofia Cervello, IBD Unit, Palermo, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.07.3
引用
收藏
页码：S163 / S164
页数：2
相关论文
共 50 条
  • [1] Corticosteroid-Sparing Effect in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab Maintenance Therapy
    Laharie, David
    Siegel, Corey A.
    Samaan, Karen
    Fischer, Deborah
    Morris, Nathan
    Redondo, Isabel
    Dulai, Parambir S.
    Jairath, Vipul
    Gisbert, Javier P.
    Matsuoka, Katsuyoshi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S635 - S635
  • [2] Corticosteroid-sparing effect of mirikizumab for the treatment of moderately-to-severely active Ulcerative Colitis: Extended induction subgroup analysis from Phase 3 trial
    Laharie, D.
    Siegel, C.
    Dulai, P.
    Matsuoka, K.
    Gisbert, J.
    Samaan, K.
    Redondo, I.
    Baygani, S.
    Paulissen, J.
    Jairath, V.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1687 - I1688
  • [3] Corticosteroid-Sparing Effect of Upadacitinib in Patients With Moderately-to-Severely Active Crohn's Disease
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel I.
    Doshi, Chirag
    Liu, Jianzhong
    Garrison, Andrew
    Loftus, Edward V.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S886 - S887
  • [4] Extended induction response in patients treated with mirikizumab with moderately to severely active ulcerative colitis in the LUCENT trials
    D'Haens, G.
    Higgins, P. D. R.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Lee, S.
    Moses, R. E.
    Redondo, I.
    Escobar, R.
    Morris, N.
    Kobayashi, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 682 - 682
  • [5] EXTENDED INDUCTION RESPONSE IN PATIENTS TREATED WITH MIRIKIZUMAB WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT TRIALS
    D'Haens, Geert
    Higgins, Peter D.
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Lee, Scott
    Moses, Richard
    Redondo, Isabel
    Escobar, Rodrigo
    Morris, Nathan
    Kobayashi, Taku
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1086 - S1086
  • [6] Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use
    Fung, Simon
    Blair, Hannah A.
    [J]. DRUGS & THERAPY PERSPECTIVES, 2024,
  • [7] EFFECT OF MIRIKIZUMAB ON CLINICAL AND ENDOSCOPIC OUTCOMES BASED ON PRIOR ADVANCED THERAPY FAILURE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Navabi, Seyedehsan
    D'Haens, Geert
    Samaan, Karen H.
    Li, Xingyuan
    Arora, Vipin
    Redondo, Isabel
    Danese, Silvio
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1089 - S1089
  • [8] Effect of mirikizumab on clinical and endoscopic outcomes based on prior advanced therapy failure in patients with moderately to severely active ulcerative colitis
    Navabi, S.
    D'Haens, G.
    Samaan, K. H.
    Li, X.
    Arora, V.
    Redondo, I.
    Danese, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 598 - 598
  • [9] MIRIKIZUMAB TREATMENT IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Dubinsky, Marla
    Lee, Scott D.
    Panaccione, Remo
    Abreu, Maria
    Vermeire, Severine
    Lissoos, Trevor
    Morris, Nathan
    Arora, Vipin
    Dong, Yan
    Naegeli, April
    Sands, Bruce
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S10 - S11
  • [10] MIRIKIZUMAB TREATMENT IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Dubinsky, Marla
    Lee, Scott D.
    Panaccione, Remo
    Abreu, Maria
    Vermeire, Severine
    Lissoos, Trevor
    Morris, Nathan
    Arora, Vipin
    Dong, Yan
    Naegeli, April
    Sands, Bruce
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S17 - S18
12345